CD25 Preselective Anti-HIV Vectors for Improved HIV Gene Therapy

As HIV continues to be a global public health problem with no effective vaccine available, new and innovative therapies, including HIV gene therapies, need to be developed. Due to low transduction efficiencies that lead to low in vivo gene marking, therapeutically relevant efficacy of HIV gene thera...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Kalomoiris, Stefanos, Lawson, Je'Tai, Chen, Rachel X., Bauer, Gerhard, Nolta, Jan A., Anderson, Joseph S.
Format: Artigo
Idioma:Inglês
Publicat: Mary Ann Liebert, Inc. 2012
Matèries:
Research Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4015076/
https://ncbi.nlm.nih.gov/pubmed/23216020
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/hgtb.2012.142
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars